Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 95

1.

NEOTROPICAL XENARTHRANS: a data set of occurrence of xenarthran species in the Neotropics.

Santos PM, Bocchiglieri A, Chiarello AG, Paglia AP, Moreira A, de Souza AC, Abba AM, Paviolo A, Gatica A, Medeiro AZ, Costa AN, Gallina AG, Yanosky AA, Jesus A, Bertassoni A, Rocha A, Bovo AAA, Bager A, Mol AC, Martensen AC, Faustino AC, Lopes AMC, Percequillo AR, Vogliotti A, Keuroghlian A, de la Colina MA, Devlin AL, García-Olaechea A, Sánchez A, Srbek-Araujo AC, Ochoa AC, Oliveira ACM, Lacerda ACR, Campelo AKN, de Oliveira Paschoal AM, Costa ARC, Meiga AYY, Jesus AS, Feijó A, Hirsch A, da Silva ALF, Botelho ALM, Regolin AL, Lanna AM, Nunes AV, Kindel A, Moraes AM, Gatti A, Noss AJ, Nobre AB, Montanarin A, Deffaci ÂC, de Albuquerque ACF, de Oliveira AK, Mangione AM, Pontes ARM, Bertoldi AT, Calouro AM, Desbiez ALJ, Fernandes A, Ferreguetti AC, da Silva MAA, Zimbres B, Luciano BFL, de Thoisy B, Niebuhr BBS, Papi B, Gómez-Valencia B, Santos BA, Lima BC, Oliveira BG, Santos BS, Campos BATP, Leles B, de Albuquerque França BR, Lim B, Oliveira CT, Cantagallo C, Lara CC, Lima CS, Gestich CC, de Melo-Soares CD, Peres CA, Kasper CB, Candia-Gallardo C, De Angelo C, Fragoso CE, de Freitas CH, Salvador CH, Brocardo CR, Melo CD, Leuchtenberger C, Braga C, Sánchez-Lalinde C, Bueno C, Luna CL, Rojano C, Hurtado CM, Dos Santos CC, Tellaeche C, Rosa C, de Campos CB, Silva CR, Kanda CZ, Jenkins CN, McDonough C, Trinca CT, da Cunha CJ, Widmer CE, Santos C, Buscariol D, Carreira DC, Carvalho DR, da Silva Ferraz D, Casali D, Thornton D, Vasconcellos DR, Barcelos D, Brown D, Ramos DL, Moreira DO, Yogui DR, Faria D, Sana DA, de Mattia DL, Henz DJ, Friedeberg DB, Carvalho DLKP, Astúa D, Queirolo D, Varela DM, Eaton DP, Dias DM, Rivadeneira EF, Rocha EC, de Abreu-Júnior EF, Carrano E, Santos EM Jr, Setz EZF, Carvalho EAR Jr, de Almeida Chiquito E, de Matos Cardoso E, Mendonça EN, D'Bastiani E, Vieira EM, Ramalho EE, Guijosa-Guadarrama E, González E, Maggiorini EV, Fischer E, Aguiar EF, Castro ÉP, de la Peña-Cuéllar E, de Castro EBV, Brítez EB, Vanderhoeven EA, Pedó E, Rocha FL, Girardi F, de Oliveira Roque F, Mazim FD, de Barros FM, Martello F, Fantacini FM, Pedrosa F, Peters FB, Abra FD, de Azevedo FC, da Silva Santos F, da Silva FG, Teixeira FZ, Perini FA, Passos FC, Carvalho F, de Azevedo FCC, de Pinho FF, Gonçalves F, Lima F, Contreras-Moreno FM, Pedroni F, Tortato FR, Santos FPR, Caruso F, Tirelli FP, Miranda FR, Rodrigues FHG, Ubaid FK, Palmeira FBL, da Silva FA, Grotta-Neto F, de Souza FL, Costa FE, Pérez-Garduza F, Delsuc F, Lemos F, Pinto FR, Boaglio GI, Massocato GF, Preuss G, Hofmann GS, Aguiar GL, Oliveira GS, Duarte GT, Beca G, Giné GAF, Batista GO, Gil GE, Gonsioroski G, Secco H, Medeiros HR, Coelho IP, Franceschi IC, Bernardi I, de la Torre JA, Zocche JJ, Seibert JB, de Faria Falcão JC, Dias JHM, Nodari JZ, Oliveira JA, Giovanelli JGR, Favoretti JPP, Polisar J, Sponchiado J, Cherem JJ, Ramírez JFM, de Toledo JJ, Duarte JMB, de Matos JR, Arrabal JP, de Faria Oshima JE, Ribeiro JF, Bogoni JA, Pacheco JJC, Schuchmann KL, Ferraz KMPMB, Dos Santos Everton L, Bailey LL, Gonçalves LO, Cullen L Jr, de Andrade LR, Trevelin LC, Bonjorne L, de Almeida Rodrigues L, Leuzinger L, Perillo LN, Araújo LS, Hufnagel L, Ribeiro LO, Bernardo LRR, Oliveira-Santos LGR, Varzinczak LH, Borges LHM, Guimarães LN, Möcklinghoff L, Oliveira MA, Magioli M, de Assis Jardim MM, de Oliveira ML, Tortato MA, Dums M, Iezzi ME, Pereira MJR, Jorge ML, de Castro Morini MS, Landis MB, Xavier MS, Barros MAS, da Silva ML, Rivero M, Zanin M, Marques MI, Alves MH, Di Bitetti MS, Alvarez MR, Graipel ME, Godoi MN, Benedetti MA, Beltrão MG, Monteiro MCM, de Paula MJ, Perilli MLL, da Silva MP, Villar N, De Albuquerque NM, Canassa NF, Filho NM, da Rosa Oliveira N, Pasqualotto N, Cáceres NC, Attias N, Favarini MO, Ribeiro OS, Gonçalves PR, da Rocha PA, Condé PA, Akkawi P, Cruz P, Lira PK, Ferreira PM, Arroyo-Gerala P, Hartmann PA, de Tarso Zuquim Antas P, Marinho PH, de Faria Peres PH, Peña-Mondragón JL, Lombardi PM, de Souza Laurindo R, Alves RSC, Grangeiro RDP, Silva RL, Beltrão-Mendes R, Bonikowski RTR, Reppucci J, Arrais RC, Sampaio R, Sartorello R, Bovendorp RS, McNab R, Hack ROE, Magalhães RA, Araújo RC, de Almeida Nobre R, Pérez RRL, Massara RL, de Paula RC, Anleu RG, Marques RV, Dornas R, Rolim SG, Cavalcanti SMC, Lima SR, Ballari SA, Santamaría SB, Silva SM, Age SG, Godim T, Sobral-Souza T, Maccarini TB, Rodrigues TF, Piovezan U, Tavares VDC, Quiroga VA, Krepschi VG, Filho VP, Bastazini VAG, de Oliveira Gasparotto VP, Orsini VS, Layme VMG, Hannibal W, Dáttilo W, de Carvalho WD, Loughry WJ, Di Blanco YE, Núñez-Regueiro MM, Giubbina MF, Passamani M, de Alagão Querido LC, da Costa Toledo GA, Ribeiro IK, Quintilham L, de Bustos S, de la Maza J, Neto JFL, de Andrade Silva KVK, Sartorello L, Rampim LE, Marás GA, Camino M, Freitas-Junior M, Perovic PG, Paolino RM, Ferreira SD, Towns V, Esperandio IB, Aximoff I, Beduschi J, Guenther M, de Cassia Bianchi R, Keuroghlian-Eaton S, Mendes SL, de Fatima Cunha L, Cirignoli S, Ciocheti G, do Prado HA, Fernandes-Ferreira H, de Sena LMM, Yamane MH, Brennand PGG, da Silva RD, Escobar S, Endo W, Hurtado RR, Gontijo NRC, Marsh LK, Severo MM, Pardo JM, Costa SA, Melo GL, Santana GG, de Miranda Mourão G, Gaspari GG, Duarte H, Cabral H, da Silva LH, Mendonça L, Barbosa LL, Dos Santos MV, Moraes MFD, Gordo M, Versiani NF, Cantero N, Pays O, Guedes PG, Colas-Rosas PF, Ribeiro P, Renaud PC, Hoogesteijn RJ, Ayala R, da Cunha RGT, Schaub R, Laurito S, Betkowski SE, Cortez S, Silva SSP, de Oliveira TG, Spironello WR, Gengler N, Hidalgo MM, Juárez R, Iglesias JA, Anacleto TC, de Souza Fialho M, Cavicchioli G, Beccato MAB, Silva MD, Neto OC, Lopes KGD, Godoy LP, Luiz MR, Rojas Bonzi VB, Ferreira GB, Oliveira MJR, Hinojosa J, de Oliveira LFB, Nagy-Reis MB, Ramirez SF, Concone HVB, Mourthe I, Martínez-Lanfranco JA, Zanoni JB, Moreira TC, Guarderas ZV, Bazilio S, Cervini M, Pinheiro MS, Morato RG, Peroni N, Trigo TC, Machado RB, Gaspari F, Koenemann JG, Rudolf JC, Benchimol M, Vieira MV, Retta LM, Santiago PGF, Ciccia PG, Estrela PC, Carvalho S, Esbérard CEL, de la Cruz YB, Castro-Prieto J, Braga RM, Cartes JL, Andrade-Núñez MJ, Denkiewicz NM, Falconi N, Pezzuti JCB, Del Castillo Cordero HF, de Sousa LC, de Gaspari Júnior RL, Santos-Filho M, Almeida JS, Thompson JJ, Dos Santos JS, Pereira-Ribeiro J, Burs K, da Silva KFM, Velilla M, da Silva MX, de la Sancha NU, Pinheiro PF, de Castilho PV, Bercê W, Assis JC, Tonetti VR, Alves-Eigenheer M, Chinem S, Honda LK, de Godoy Bergallo H, Alberici V, Wallace R, Krauer JMC, Ribeiro MC, Galetti M.

Ecology. 2019 Jul;100(7):e02663. doi: 10.1002/ecy.2663. Epub 2019 Apr 23.

PMID:
31013542
2.

Transactivation of human endogenous retrovirus K (HERV-K) by KSHV promotes Kaposi's sarcoma development.

Dai L, Del Valle L, Miley W, Whitby D, Ochoa AC, Flemington EK, Qin Z.

Oncogene. 2018 Aug;37(33):4534-4545. doi: 10.1038/s41388-018-0282-4. Epub 2018 May 10.

3.

A novel patient-derived xenograft model for claudin-low triple-negative breast cancer.

Matossian MD, Burks HE, Bowles AC, Elliott S, Hoang VT, Sabol RA, Pashos NC, O'Donnell B, Miller KS, Wahba BM, Bunnell BA, Moroz K, Zea AH, Jones SD, Ochoa AC, Al-Khami AA, Hossain F, Riker AI, Rhodes LV, Martin EC, Miele L, Burow ME, Collins-Burow BM.

Breast Cancer Res Treat. 2018 Jun;169(2):381-390. doi: 10.1007/s10549-018-4685-2. Epub 2018 Feb 1.

4.

Exogenous lipid uptake induces metabolic and functional reprogramming of tumor-associated myeloid-derived suppressor cells.

Al-Khami AA, Zheng L, Del Valle L, Hossain F, Wyczechowska D, Zabaleta J, Sanchez MD, Dean MJ, Rodriguez PC, Ochoa AC.

Oncoimmunology. 2017 Jun 30;6(10):e1344804. doi: 10.1080/2162402X.2017.1344804. eCollection 2017.

5.

Energy metabolic pathways control the fate and function of myeloid immune cells.

Al-Khami AA, Rodriguez PC, Ochoa AC.

J Leukoc Biol. 2017 Aug;102(2):369-380. doi: 10.1189/jlb.1VMR1216-535R. Epub 2017 May 17. Review.

6.

Fuelling the mechanisms of asthma: Increased fatty acid oxidation in inflammatory immune cells may represent a novel therapeutic target.

Al-Khami AA, Ghonim MA, Del Valle L, Ibba SV, Zheng L, Pyakurel K, Okpechi SC, Garay J, Wyczechowska D, Sanchez-Pino MD, Rodriguez PC, Boulares AH, Ochoa AC.

Clin Exp Allergy. 2017 Sep;47(9):1170-1184. doi: 10.1111/cea.12947. Epub 2017 Jul 5.

7.

Arginine Metabolism in Myeloid Cells Shapes Innate and Adaptive Immunity.

Rodriguez PC, Ochoa AC, Al-Khami AA.

Front Immunol. 2017 Feb 7;8:93. doi: 10.3389/fimmu.2017.00093. eCollection 2017. Review.

8.

Cellular transformation of human mammary epithelial cells by SATB2.

Yu W, Ma Y, Ochoa AC, Shankar S, Srivastava RK.

Stem Cell Res. 2017 Mar;19:139-147. doi: 10.1016/j.scr.2017.01.011. Epub 2017 Feb 1.

9.

Metabolic reprogramming of myeloid-derived suppressor cells (MDSC) in cancer.

Al-Khami AA, Rodriguez PC, Ochoa AC.

Oncoimmunology. 2016 Jun 27;5(8):e1200771. doi: 10.1080/2162402X.2016.1200771. eCollection 2016 Aug.

10.

Development and evaluation of a host-targeted antiviral that abrogates herpes simplex virus replication through modulation of arginine-associated metabolic pathways.

Sanchez MD, Ochoa AC, Foster TP.

Antiviral Res. 2016 Aug;132:13-25. doi: 10.1016/j.antiviral.2016.05.009. Epub 2016 May 15.

11.

CD147 and downstream ADAMTSs promote the tumorigenicity of Kaposi's sarcoma-associated herpesvirus infected endothelial cells.

Dai L, Trillo-Tinoco J, Chen Y, Bonstaff K, Del Valle L, Parsons C, Ochoa AC, Zabaleta J, Toole BP, Qin Z.

Oncotarget. 2016 Jan 26;7(4):3806-18. doi: 10.18632/oncotarget.6584.

12.

Ceramides promote apoptosis for virus-infected lymphoma cells through induction of ceramide synthases and viral lytic gene expression.

Dai L, Trillo-Tinoco J, Bai A, Chen Y, Bielawski J, Del Valle L, Smith CD, Ochoa AC, Qin Z, Parsons C.

Oncotarget. 2015 Sep 15;6(27):24246-60.

13.

Inhibition of Fatty Acid Oxidation Modulates Immunosuppressive Functions of Myeloid-Derived Suppressor Cells and Enhances Cancer Therapies.

Hossain F, Al-Khami AA, Wyczechowska D, Hernandez C, Zheng L, Reiss K, Valle LD, Trillo-Tinoco J, Maj T, Zou W, Rodriguez PC, Ochoa AC.

Cancer Immunol Res. 2015 Nov;3(11):1236-47. doi: 10.1158/2326-6066.CIR-15-0036. Epub 2015 May 29.

14.

l-Arginine depletion blunts antitumor T-cell responses by inducing myeloid-derived suppressor cells.

Fletcher M, Ramirez ME, Sierra RA, Raber P, Thevenot P, Al-Khami AA, Sanchez-Pino D, Hernandez C, Wyczechowska DD, Ochoa AC, Rodriguez PC.

Cancer Res. 2015 Jan 15;75(2):275-83. doi: 10.1158/0008-5472.CAN-14-1491. Epub 2014 Nov 18.

15.

The stress-response sensor chop regulates the function and accumulation of myeloid-derived suppressor cells in tumors.

Thevenot PT, Sierra RA, Raber PL, Al-Khami AA, Trillo-Tinoco J, Zarreii P, Ochoa AC, Cui Y, Del Valle L, Rodriguez PC.

Immunity. 2014 Sep 18;41(3):389-401. doi: 10.1016/j.immuni.2014.08.015.

16.

Arginase I levels are decreased in the plasma of pediatric patients with atopic dermatitis.

Dimitriades V, Rodriguez PC, Zabaleta J, Ochoa AC.

Ann Allergy Asthma Immunol. 2014 Sep;113(3):271-5. doi: 10.1016/j.anai.2014.06.010. Epub 2014 Jul 11.

17.

Rescue of notch-1 signaling in antigen-specific CD8+ T cells overcomes tumor-induced T-cell suppression and enhances immunotherapy in cancer.

Sierra RA, Thevenot P, Raber PL, Cui Y, Parsons C, Ochoa AC, Trillo-Tinoco J, Del Valle L, Rodriguez PC.

Cancer Immunol Res. 2014 Aug;2(8):800-11. doi: 10.1158/2326-6066.CIR-14-0021. Epub 2014 May 15.

18.

Subpopulations of myeloid-derived suppressor cells impair T cell responses through independent nitric oxide-related pathways.

Raber PL, Thevenot P, Sierra R, Wyczechowska D, Halle D, Ramirez ME, Ochoa AC, Fletcher M, Velasco C, Wilk A, Reiss K, Rodriguez PC.

Int J Cancer. 2014 Jun 15;134(12):2853-64. doi: 10.1002/ijc.28622. Epub 2013 Dec 3.

19.

The antimicrobial agent C31G is effective for therapy for HSV-1 ocular keratitis in the rabbit eye model.

Hill JM, Stern EM, Bhattacharjee PS, Malamud D, Clement C, Rodriguez P, Lukiw WJ, Ochoa AC, Foster TP, Velasco C, McFerrin HE Jr.

Antiviral Res. 2013 Oct;100(1):14-9. doi: 10.1016/j.antiviral.2013.07.002. Epub 2013 Jul 13.

20.

Minocycline blocks asthma-associated inflammation in part by interfering with the T cell receptor-nuclear factor κB-GATA-3-IL-4 axis without a prominent effect on poly(ADP-ribose) polymerase.

Naura AS, Kim H, Ju J, Rodriguez PC, Jordan J, Catling AD, Rezk BM, Abd Elmageed ZY, Pyakurel K, Tarhuni AF, Abughazleh MQ, Errami Y, Zerfaoui M, Ochoa AC, Boulares AH.

J Biol Chem. 2013 Jan 18;288(3):1458-68. doi: 10.1074/jbc.M112.419580. Epub 2012 Nov 26.

21.

Metabolism of L-arginine by myeloid-derived suppressor cells in cancer: mechanisms of T cell suppression and therapeutic perspectives.

Raber P, Ochoa AC, Rodríguez PC.

Immunol Invest. 2012;41(6-7):614-34. doi: 10.3109/08820139.2012.680634. Review.

22.

L-arginine deprivation regulates cyclin D3 mRNA stability in human T cells by controlling HuR expression.

Rodriguez PC, Hernandez CP, Morrow K, Sierra R, Zabaleta J, Wyczechowska DD, Ochoa AC.

J Immunol. 2010 Nov 1;185(9):5198-204. doi: 10.4049/jimmunol.1001224. Epub 2010 Oct 1.

23.

Bone marrow myeloid-derived suppressor cells (MDSCs) inhibit graft-versus-host disease (GVHD) via an arginase-1-dependent mechanism that is up-regulated by interleukin-13.

Highfill SL, Rodriguez PC, Zhou Q, Goetz CA, Koehn BH, Veenstra R, Taylor PA, Panoskaltsis-Mortari A, Serody JS, Munn DH, Tolar J, Ochoa AC, Blazar BR.

Blood. 2010 Dec 16;116(25):5738-47. doi: 10.1182/blood-2010-06-287839. Epub 2010 Aug 31.

24.

Requirement for inducible nitric oxide synthase in chronic allergen exposure-induced pulmonary fibrosis but not inflammation.

Naura AS, Zerfaoui M, Kim H, Abd Elmageed ZY, Rodriguez PC, Hans CP, Ju J, Errami Y, Park J, Ochoa AC, Boulares AH.

J Immunol. 2010 Sep 1;185(5):3076-85. doi: 10.4049/jimmunol.0904214. Epub 2010 Jul 28.

25.

Association of haplotypes of inflammation-related genes with gastric preneoplastic lesions in African Americans and Caucasians.

Zabaleta J, Camargo MC, Ritchie MD, Piazuelo MB, Sierra RA, Turner SD, Delgado A, Fontham ET, Schneider BG, Correa P, Ochoa AC.

Int J Cancer. 2011 Feb 1;128(3):668-75. doi: 10.1002/ijc.25385.

26.

Cytokine genetic polymorphisms and prostate cancer aggressiveness.

Zabaleta J, Su LJ, Lin HY, Sierra RA, Hall MC, Sartor AO, Clark PE, Hu JJ, Ochoa AC.

Carcinogenesis. 2009 Aug;30(8):1358-62. doi: 10.1093/carcin/bgp124. Epub 2009 May 27.

27.

Tumor-infiltrating regulatory dendritic cells inhibit CD8+ T cell function via L-arginine metabolism.

Norian LA, Rodriguez PC, O'Mara LA, Zabaleta J, Ochoa AC, Cella M, Allen PM.

Cancer Res. 2009 Apr 1;69(7):3086-94. doi: 10.1158/0008-5472.CAN-08-2826. Epub 2009 Mar 17.

28.

Arginase I-producing myeloid-derived suppressor cells in renal cell carcinoma are a subpopulation of activated granulocytes.

Rodriguez PC, Ernstoff MS, Hernandez C, Atkins M, Zabaleta J, Sierra R, Ochoa AC.

Cancer Res. 2009 Feb 15;69(4):1553-60. doi: 10.1158/0008-5472.CAN-08-1921. Epub 2009 Feb 5.

29.

T cell CD3 receptor zeta (TCRzeta)-chain expression in children with idiopathic nephrotic syndrome.

Aviles DH, Vehaskari MV, Culotta KS, Manning J, Ochoa AC, Zea AH.

Pediatr Nephrol. 2009 Apr;24(4):769-73. doi: 10.1007/s00467-008-1061-1. Epub 2008 Dec 10.

PMID:
19082633
30.

Arginine regulation by myeloid derived suppressor cells and tolerance in cancer: mechanisms and therapeutic perspectives.

Rodríguez PC, Ochoa AC.

Immunol Rev. 2008 Apr;222:180-91. doi: 10.1111/j.1600-065X.2008.00608.x. Review.

31.

Interactions of cytokine gene polymorphisms in prostate cancer risk.

Zabaleta J, Lin HY, Sierra RA, Hall MC, Clark PE, Sartor OA, Hu JJ, Ochoa AC.

Carcinogenesis. 2008 Mar;29(3):573-8. doi: 10.1093/carcin/bgm277. Epub 2008 Jan 3.

PMID:
18174250
32.

Ethnic differences in cytokine gene polymorphisms: potential implications for cancer development.

Zabaleta J, Schneider BG, Ryckman K, Hooper PF, Camargo MC, Piazuelo MB, Sierra RA, Fontham ET, Correa P, Williams SM, Ochoa AC.

Cancer Immunol Immunother. 2008 Jan;57(1):107-14. Epub 2007 Jul 6.

PMID:
17618436
33.

Arginase, prostaglandins, and myeloid-derived suppressor cells in renal cell carcinoma.

Ochoa AC, Zea AH, Hernandez C, Rodriguez PC.

Clin Cancer Res. 2007 Jan 15;13(2 Pt 2):721s-726s. Review.

34.

Innovations and challenges in renal cell carcinoma: summary statement from the Second Cambridge Conference.

Atkins MB, Ernstoff MS, Figlin RA, Flaherty KT, George DJ, Kaelin WG Jr, Kwon ED, Libermann TA, Linehan WM, McDermott DF, Ochoa AC, Pantuck AJ, Rini BI, Rosen MA, Sosman JA, Sukhatme VP, Vieweg JW, Wood CG, King L.

Clin Cancer Res. 2007 Jan 15;13(2 Pt 2):667s-670s. Review.

35.

Decreased expression of CD3zeta and nuclear transcription factor kappa B in patients with pulmonary tuberculosis: potential mechanisms and reversibility with treatment.

Zea AH, Culotta KS, Ali J, Mason C, Park HJ, Zabaleta J, Garcia LF, Ochoa AC.

J Infect Dis. 2006 Nov 15;194(10):1385-93. Epub 2006 Oct 4.

PMID:
17054067
36.

L-arginine availability regulates T-lymphocyte cell-cycle progression.

Rodriguez PC, Quiceno DG, Ochoa AC.

Blood. 2007 Feb 15;109(4):1568-73. Epub 2006 Oct 5.

37.

In vitro and in vivo complementation of the Helicobacter pylori arginase mutant using an intergenic chromosomal site.

Langford ML, Zabaleta J, Ochoa AC, Testerman TL, McGee DJ.

Helicobacter. 2006 Oct;11(5):477-93.

38.

Association of interleukin-1beta gene polymorphisms with precancerous gastric lesions in African Americans and Caucasians.

Zabaleta J, Camargo MC, Piazuelo MB, Fontham E, Schneider BG, Sicinschi LA, Ferrante W, Balart L, Correa P, Ochoa AC.

Am J Gastroenterol. 2006 Jan;101(1):163-71.

PMID:
16405550
39.

T cell dysfunction in cancer: role of myeloid cells and tumor cells regulating amino acid availability and oxidative stress.

Rodríguez PC, Ochoa AC.

Semin Cancer Biol. 2006 Feb;16(1):66-72. Epub 2005 Nov 17. Review. No abstract available.

PMID:
16298138
40.

Mechanisms of tumor evasion.

Campoli M, Ferrone S, Zea AH, Rodriguez PC, Ochoa AC.

Cancer Treat Res. 2005;123:61-88. Review.

PMID:
16211866
41.

Arginase I in myeloid suppressor cells is induced by COX-2 in lung carcinoma.

Rodriguez PC, Hernandez CP, Quiceno D, Dubinett SM, Zabaleta J, Ochoa JB, Gilbert J, Ochoa AC.

J Exp Med. 2005 Oct 3;202(7):931-9. Epub 2005 Sep 26.

42.

Crystal structure of human arginase I at 1.29-A resolution and exploration of inhibition in the immune response.

Di Costanzo L, Sabio G, Mora A, Rodriguez PC, Ochoa AC, Centeno F, Christianson DW.

Proc Natl Acad Sci U S A. 2005 Sep 13;102(37):13058-63. Epub 2005 Sep 2.

43.

L-Arginine modulates CD3zeta expression and T cell function in activated human T lymphocytes.

Zea AH, Rodriguez PC, Culotta KS, Hernandez CP, DeSalvo J, Ochoa JB, Park HJ, Zabaleta J, Ochoa AC.

Cell Immunol. 2004 Nov-Dec;232(1-2):21-31. Epub 2005 Feb 23.

PMID:
15922712
44.

Arginase-producing myeloid suppressor cells in renal cell carcinoma patients: a mechanism of tumor evasion.

Zea AH, Rodriguez PC, Atkins MB, Hernandez C, Signoretti S, Zabaleta J, McDermott D, Quiceno D, Youmans A, O'Neill A, Mier J, Ochoa AC.

Cancer Res. 2005 Apr 15;65(8):3044-8.

45.

Mechanisms of tumor evasion from the immune response.

Rodríguez PC, Zea AH, Ochoa AC.

Cancer Chemother Biol Response Modif. 2003;21:351-64. Review.

PMID:
15338755
46.

Arginase I production in the tumor microenvironment by mature myeloid cells inhibits T-cell receptor expression and antigen-specific T-cell responses.

Rodriguez PC, Quiceno DG, Zabaleta J, Ortiz B, Zea AH, Piazuelo MB, Delgado A, Correa P, Brayer J, Sotomayor EM, Antonia S, Ochoa JB, Ochoa AC.

Cancer Res. 2004 Aug 15;64(16):5839-49.

47.

Helicobacter pylori arginase inhibits T cell proliferation and reduces the expression of the TCR zeta-chain (CD3zeta).

Zabaleta J, McGee DJ, Zea AH, Hernández CP, Rodriguez PC, Sierra RA, Correa P, Ochoa AC.

J Immunol. 2004 Jul 1;173(1):586-93.

48.

Decreased expression of T-cell NF-kappaB p65 subunit in steroid-resistant nephrotic syndrome.

Aviles DH, Matti Vehaskari V, Manning J, Ochoa AC, Zea AH.

Kidney Int. 2004 Jul;66(1):60-7.

49.

Purification and characterization of Helicobacter pylori arginase, RocF: unique features among the arginase superfamily.

McGee DJ, Zabaleta J, Viator RJ, Testerman TL, Ochoa AC, Mendz GL.

Eur J Biochem. 2004 May;271(10):1952-62.

50.

L-arginine consumption by macrophages modulates the expression of CD3 zeta chain in T lymphocytes.

Rodriguez PC, Zea AH, DeSalvo J, Culotta KS, Zabaleta J, Quiceno DG, Ochoa JB, Ochoa AC.

J Immunol. 2003 Aug 1;171(3):1232-9.

Supplemental Content

Loading ...
Support Center